Cited by 540Gastrointestinal motility and disordersGut microbiota and healthInflammatory Bowel Disease

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators

Open access

Piche, T, Barbara, G, Aubert, P, Bruley des Varannes, S, Dainese, R, Nano, J L, Cremon, C, Stanghellini, V, De Giorgio, R, Galmiche, J P, Neunlist, M·2009·Gut

DOI 10.1136/gut.2007.140806

Open this paper in CoChat — free account Open PDF

Abstract

Background: Growing evidence suggests that patients with irritable bowel syndrome (IBS) have increased intestinal permeability. In addition, mucosal soluble mediators are involved in the pathophysiology of pain in IBS. We aimed to investigate (1) paracellular permeability in colonic biopsies of patients with IBS; and (2) the ability of soluble factors from colonic biopsies to reproduce these alterations in vitro. Methods: Paracellular permeability in colonic biopsies of healthy subjects and patients with IBS was measured by mounting the biopsies in Ussing chambers. Cleared supernatant (SUP) of the culture from colonic biopsies was collected and applied to Caco-2 cells for 48 h. Paracellular permeability and transepithelial resistance (TER) were evaluated. mRNA expression of the tight junction proteins, zonula occludens (ZO)-1 and occludin, was assessed in colonic biopsies. Abdominal pain was assessed using a validated questionnaire. Results: Permeability of colonic biopsies was significantly higher in patients with IBS compared to healthy subjects. These changes were associated with significantly lower expression of ZO-1 mRNA in biopsies of IBS as compared to healthy subjects. Compared to healthy subjects, SUP of IBS markedly reduced TER and significantly increased permeability in Caco-2 cells. SUP of IBS patients induced a significant decrease of ZO-1 mRNA in Caco-2 as compared to healthy subjects. SUP-induced increased paracellular permeability correlated with the severity of abdominal pain. Conclusions: Our study shows that colonic soluble mediators are able to reproduce functional (permeability) and molecular (ZO-1 mRNA expression) alterations observed in IBS patients. These findings might pave the way both to identify novel biomarkers as well as new therapeutic targets in IBS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/gut.2007.140806

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475
Self-citation
Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome
Spiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R. (2000) · Gut · doi:10.1136/gut.47.6.804 · Cited by 1,155
Mast Cell-Dependent Excitation of Visceral-Nociceptive Sensory Neurons in Irritable Bowel Syndrome
Barbara, G., Wang, B., Stanghellini, V., de Giorgio, R., Cremon, C., Di Nardo, G., Trevisani, M., Campi, B., Geppetti, P., Tonini, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.039 · Cited by 783
Self-citation
Role for protease activity in visceral pain in irritable bowel syndrome
Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade-Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29255 · Cited by 591 · cited 3×
“Previous studies (10, 11) have shown that candidates such as protease and histamine are involved in the effects of SUP of IBS upon the neuronal excitability.”
Self-citation
Neutrophil Transmigration in Inflammatory Bowel Disease Is Associated with Differential Expression of Epithelial Intercellular Junction Proteins
Kucharzik, T. F., Walsh, S. V., Chen, J. Z., Parkos, C. A., & Nusrat, A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63051-9 · Cited by 523
IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells
Nusrat, A., Turner, J. R., & Madara, J. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.5.g851 · Cited by 499
Abnormal Intestinal Permeability in Subgroups of Diarrhea-Predominant Irritable Bowel Syndromes
Dunlop, S. P., Hebden, J., Campbell, E., Naesdal, J., Olbe, L., Perkins, A. C., & Spiller, R. C. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00672.x · Cited by 476
Enteric Glia Regulate Intestinal Barrier Function and Inflammation Via Release of S-Nitrosoglutathione
Savidge, T., Newman, P., Pothoulakis, C., Rühl, A., Neunlist, M., Bourreille, A., Hurst, R. D., & Sofroniew, M. V. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.051 · Cited by 435
Self-citation

Flagged first, then by citations

Show all 33 references

Research works printed but not linked: 2

10.1111/j.1572-0241.2006.00667.x · DOI
10.1136/gut.47.6.804 · DOI · Paper page

Sorted by citations

Items 101–200 of 540

Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
(2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8886 · Cited by 106
Melatonin ameliorates necrotizing enterocolitis by preventing Th17/Treg imbalance through activation of the AMPK/SIRT1 pathway
Ma, F., Hu, H., Gao, X., Cai, Y., Zhou, J., Liang, P., Lv, J., He, Q., Shi, C., Hu, D., et al. (2020) · Theranostics · doi:10.7150/thno.45862 · Cited by 107
Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome
Hasler, W. L., Grabauskas, G., Singh, P., & Owyang, C. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14339 · Cited by 105
Immune activation in irritable bowel syndrome: what is the evidence?
Aguilera‐Lizarraga, J., Hussein, H., & Boeckxstaens, G. E. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00700-9 · Cited by 109
A marketed fermented dairy product containing Bifidobacterium lactis CNCM I‐2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats
Agostini, S., Goubern, M., Tondereau, V., Salvador–Cartier, C., Bézirard, V., Lévèque, M., Keränen, H., Théodorou, V., Bourdu-Naturel, S., Goupil-Feuillerat, N., et al. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01865.x · Cited by 106
Randomised controlled trial of mesalazine in IBS
Barbara, G., Cremon, C., Annese, V., Basilisco, G., Bazzoli, F., Bellini, M., Benedetti, A., Benini, L., Bossa, F., Buldrini, P., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-308188 · Cited by 107
Self-citation
Inflammation in irritable bowel syndrome: Myth or new treatment target?
Sinagra, E., Pompei, G., Tomasello, G., Cappello, F., Morreale, G. C., Amvrosiadis, G., Rossi, F., Monte, A. I. L., Rizzo, A. G., & Raimondo, D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2242 · Cited by 104
Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis
Carco, C., Young, W., Gearry, R. B., Talley, N. J., McNabb, W. C., & Roy, N. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00468 · Cited by 105
The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate
Khaleghi, S., Ju, J. M., Lamba, A., & Murray, J. A. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15616576 · Cited by 97
Luminal Cysteine-Proteases Degrade Colonic Tight Junction Structure and Are Responsible for Abdominal Pain in Constipation-Predominant IBS
Annaházi, A., Ferrier, L., Bézirard, V., Lévêque, M., Eutamène, H., Ait-Belgnaoui, A., Coëffier, M., Ducrotté, P., Róka, R., Inczefi, O., et al. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.152 · Cited by 96
Self-citation
Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome: IBS-like symptoms in quiescent CD patients
Piche, T., Ducrotté, P., Sabate, J. M., Coffin, B., Zerbib, F., Dapoigny, M., Hua, M., Marine-barjoan, E., Dainese, R., & Hébuterne, X. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01502.x · Cited by 95
Self-citation
Correlation of Intestinal Mucosal Healing and Tight Junction Protein Expression in Ulcerative Colitis Patients
Tan, Y., Guan, Y., Sun, Y., & Zheng, C. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.11.011 · Cited by 94
Leaky Gut in Patients with Diarrhea-Predominant Irritable Bowel Syndrome and Inactive Ulcerative Colitis
Gecse, K., Roka, R., Séra, T., Rosztóczy, A., Annaházi, A., Izbéki, F., Nagy, F., Molnár, T., Szepes, Z., Pávics, L., et al. (2011) · Digestion · doi:10.1159/000333083 · Cited by 88
Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome
Fourie, N. H., Peace, R. M., Abey, S. K., Sherwin, L. B., Rahim-Williams, B., Smyser, P. A., Wiley, J. W., & Henderson, W. A. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.04.009 · Cited by 91
Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases
Barmeyer, C., Fromm, M., & Schulzke, J. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1914-6 · Cited by 91
Stress-Related Alterations of Visceral Sensation: Animal Models for Irritable Bowel Syndrome Study
Larauche, M. H., Mulak, A., & Taché, Y. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.3.213 · Cited by 92
Brain–Gut Interactions Increase Peripheral Nociceptive Signaling in Mice With Postinfectious Irritable Bowel Syndrome
Ibeakanma, C. O., Ochoa‐Cortés, F., Miranda‐Morales, M., McDonald, T. G., Spreadbury, I., Cénac, N., Cattaruzza, F., Hurlbut, D. J., Vanner, S., Bunnett, N. W., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.006 · Cited by 92
Is fecal microbiota transplantation ( FMT ) an effective treatment for patients with functional gastrointestinal disorders ( FGID )?
Pinn, D. M., Aroniadis, O. C., & Brandt, L. J. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12479 · Cited by 93
The effects of a multispecies probiotic on migraine and markers of intestinal permeability – results of a randomized placebo-controlled study
de Roos, N. M., van Hemert, S., Rovers, J. M. P., Smits, M. G., & Witteman, B. J. M. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.57 · Cited by 89
Colonic treatments and targets: issues and opportunities
McConnell, E. L., Liu, F., & Basit, A. W. (2009) · Journal of drug targeting · doi:10.1080/10611860902839502 · Cited by 89
Impact of Shiftwork on Irritable Bowel Syndrome and Functional Dyspepsia
Kim, H. I., Jung, S.-A., Choi, J. Y., Kim, S., Jung, H., Shim, K., & Yoo, K. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.3.431 · Cited by 91
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity
Barbaro, M. R., Cremon, C., Morselli‐Labate, A. M., Sabatino, A. D., Giuffrida, P., Corazza, G. R., Stefano, M. D., Caio, G., Latella, G., Ciacci, C., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319281 · Cited by 88
Self-citation
Combat‐training increases intestinal permeability, immune activation and gastrointestinal symptoms in soldiers
Li, X., Kan, E. M., Lu, J., Cao, Y., Wong, R. K. M., Keshavarzian, A., & Wilder‐Smith, C. H. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12269 · Cited by 87
Dietary leucine regulates the intestinal immune status, immune-related signalling molecules and tight junction transcript abundance in grass carp (Ctenopharyngodon idella)
Jiang, W., Deng, Y.-P., Liu, Y., Qu, B., Jiang, J., Kuang, S., Tang, L. Y., Tang, W., Wu, P., Zhang, Y., et al. (2015) · Aquaculture · doi:10.1016/j.aquaculture.2015.04.005 · Cited by 88
Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome
Theodorou, V., Ait-Belgnaoui, A., Agostini, S., & Eutamene, H. (2014) · Gut Microbes · doi:10.4161/gmic.29796 · Cited by 83
The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease
Inczefi, O., Bacsúr, P., Resál, T., Keresztes, C., & Molnár, T. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.718710 · Cited by 90
Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation
Zhang, D., Zhang, L., Yue, F., Zheng, Y., & Russell, R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0589 · Cited by 86
The Role of Mast Cells in Irritable Bowel Syndrome
Lee, K. N., & Lee, O. Y. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/2031480 · Cited by 90
Transient receptor potential ion channel function in sensory transduction and cellular signaling cascades underlying visceral hypersensitivity
Balemans, D., Boeckxstaens, G. E., Talavera, K., & Wouters, M. M. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00401.2016 · Cited by 90
Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics
Principi, N., Cozzali, R., Farinelli, E., Brusaferro, A., & Esposito, S. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.12.013 · Cited by 94
MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1
Hou, Q., Huang, Y., Zhu, S.-L., Li, P., Chen, X., Hou, Z., & Liu, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000486059 · Cited by 81
Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption
Terciolo, C., Dapoigny, M. C., & André, F. (2019) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s181590 · Cited by 94
Irritable bowel syndrome: Role of food in pathogenesis and management
Morcos, A. I., Dinan, T. G., & Quigley, E. M. M. (2009) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2009.00392.x · Cited by 85
The joint power of sex and stress to modulate brain–gut–microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome
Pigrau, M., Rodiño‐Janeiro, B. K., Casado‐Bedmar, M., Lobo, B., Vicario, M., Santos, J., & Alonso, C. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12717 · Cited by 83
Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel Syndrome
Barbara, G., Zecchi, L., Barbaro, M. R., Cremon, C., Bellacosa, L., Marcellini, M. M., GIORGIO, R. D., Corinaldesi, R., & Stanghellini, V. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318264e918 · Cited by 82
Self-citation
Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift
Jung, H., & Talley, N. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18060 · Cited by 73
Oral tolerance is inefficient in neonatal mice due to a physiological vitamin A deficiency
Turfkruyer, M., Rekima, A., Macchiaverni, P., Bourhis, L. L., Muncan, V., BRINK, G. R. V. D., Tulić, M. K., & Verhasselt, V. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.114 · Cited by 78
Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016
Layer, P., Andresen, V., Allescher, H. ‐., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel‐Stengel, M., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1591-4794 · Cited by 81
Astragalus polysaccharide reduces inflammatory response by decreasing permeability of LPS-infected Caco2 cells
Wang, X., Li, Y., Yang, X., & Yao, J. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.07.013 · Cited by 77
Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity
Halliez, M. C. M., Motta, J., Feener, T. D., Guérin, G., Goff, L. L., François, A., Colasse, É., Favennec, L., Gargala, G., Lapointe, T. K., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00144.2015 · Cited by 83
Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
Porter, C. K., Cash, B. D., Pimentel, M., Akinseye, A., & Riddle, M. S. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-55 · Cited by 77
Presence of commensal house dust mite allergen in human gastrointestinal tract: a potential contributor to intestinal barrier dysfunction
Tulić, M. K., Vivinus-Nébot, M., Rekima, A., Medeiros, S. R., Bonnart, C., Shi, H., Walker, A. W., Dainese, R., Boyer, J., Vergnolle, N., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-310523 · Cited by 74
Self-citation
Fecal Short-Chain Fatty Acid Ratios as Related to Gastrointestinal and Depressive Symptoms in Young Adults
Müller, B., Rasmusson, A. J., Just, D., Jayarathna, S., Moazzami, A. A., Novičić, Z. K., & Cunningham, J. L. (2021) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000965 · Cited by 76
The effects of repeated social interaction stress on behavioural and physiological parameters in a stress-sensitive mouse strain
Savignac, H. M., Hyland, N. P., Dinan, T. G., & Cryan, J. F. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.049 · Cited by 75
Cytokines and irritable bowel syndrome: Where do we stand?
Bashashati, M., Rezaei, N., Andrews, C. N., Chen, C., Daryani, N. E., Sharkey, K. A., & Storr, M. (2011) · Cytokine · doi:10.1016/j.cyto.2011.11.019 · Cited by 74
Pathogenesis of Human Enterovirulent Bacteria: Lessons from Cultured, Fully Differentiated Human Colon Cancer Cell Lines
Moal, V. L.-L., & Servin, A. L. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-12 · Cited by 88
Current insights into the innate immune system dysfunction in irritable bowel syndrome
Lazaridis, N. (2018) · Annals of Gastroenterology · doi:10.20524/aog.2018.0229 · Cited by 77
Dietary Proteins and Functional Gastrointestinal Disorders
Boettcher, E., & Crowe, S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.97 · Cited by 98
Investigating Gut Permeability in Animal Models of Disease
González-González, M., Díaz-Zepeda, C., Eyzaguirre‐Velásquez, J., González‐Arancibia, C., Bravo, J. A., & Julio‐Pieper, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01962 · Cited by 71
Inflammatory bowel disease and irritable bowel syndrome
Barbara, G., Cremon, C., & Stanghellini, V. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000070 · Cited by 72
Self-citation
Literature Review of Gastrointestinal Physiology in the Elderly, in Pediatric Patients, and in Patients with Gastrointestinal Diseases.
Bai, J. P. F., Burckart, G., & Mulberg, A. (2016) · Journal of Pharmacy and Science · doi:10.1002/jps.24696 · Cited by 64
Multispecies probiotic protects gut barrier function in experimental models
Vivinus-Nébot, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6832 · Cited by 72
Palmitic Acid Affects Intestinal Epithelial Barrier Integrity and Permeability In Vitro
Gori, M., Altomare, A., Cocca, S., Solida, E., Ribolsi, M., Carotti, S., Rainer, A., Francesconi, M. A., Morini, S., Cicala, M., et al. (2020) · Antioxidants · doi:10.3390/antiox9050417 · Cited by 68
Questioning the Bacterial Overgrowth Hypothesis of Irritable Bowel Syndrome: An Epidemiologic and Evolutionary Perspective
Spiegel, B. M. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.02.030 · Cited by 67
Serum zonulin is elevated in IBS and correlates with stool frequency in IBS‐D
Singh, P., Silvester, J. A., Chen, X., Xu, H. J., Sawhney, V., Rangan, V., Iturrino, J., Nee, J. W., Duerksen, D. R., & Lembo, A. J. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619826419 · Cited by 71
Abnormal Barrier Function in Gastrointestinal Disorders
Farré, R., & Vicario, M. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_107 · Cited by 67
Chronic stress and intestinal permeability: Lubiprostone regulates glucocorticoid receptor‐mediated changes in colon epithelial tight junction proteins, barrier function, and visceral pain in the rodent and human
Zong, Y., Zhu, S., Zhang, S., Zheng, G., Wiley, J. W., & Hong, S. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13477 · Cited by 71
Simulator of the Human Intestinal Microbial Ecosystem (SHIME®): Current Developments, Applications, and Future Prospects
Zhu, W., Zhang, X., Wang, D., Yao, Q., Ma, G., & Fan, X. (2024) · Pharmaceuticals · doi:10.3390/ph17121639 · Cited by 71
Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea
Vázquez‐Roque, M. I., Camilleri, M., Smyrk, T. C., Murray, J. A., O’Neill, J., Carlson, P., Lamsam, J. L., Eckert, D. J., Janzow, D., Burton, D. B., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00294.2012 · Cited by 67
A review on fish immuno-nutritional response to indispensable amino acids in relation to TOR, NF-κB and Nrf2 signaling pathways: Trends and prospects
Habte‐Tsion, H. (2019) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2019.110389 · Cited by 64
A Potential Role for Stress-Induced Microbial Alterations in IgA-Associated Irritable Bowel Syndrome with Diarrhea
Rengarajan, S., Knoop, K. A., Rengarajan, A., Chai, J. N., Grajales‐Reyes, J. G., Samineni, V. K., Russler-Germain, E. V., Ranganathan, P., Fasano, A., Sayuk, G. S., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100124 · Cited by 63
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome
Gargari, G., Mantegazza, G., Cremon, C., Taverniti, V., Valenza, A., Barbaro, M., Marasco, G., Duncan, R., Fiore, W., Ferrari, R., et al. (2024) · Gut microbes · doi:10.1080/19490976.2023.2298246 · Cited by 55
Self-citation
Changes in integrity of the gill during histidine deficiency or excess due to depression of cellular anti-oxidative ability, induction of apoptosis, inflammation and impair of cell-cell tight junctions related to Nrf2, TOR and NF-κB signaling in fish
Jiang, W., Feng, L., Qu, B., Wu, P., Kuang, S., Jiang, J., Tang, L. Y., Tang, W., Zhang, Y., Zhou, X., et al. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.07.002 · Cited by 60
Epigenetic mechanisms in irritable bowel syndrome
Mahurkar-Joshi, S., & Chang, L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00805 · Cited by 59
Can the gut be the missing piece in uncovering PD pathogenesis?
Chapelet, G., Leclair‐Visonneau, L., Clairembault, T., Neunlist, M., & Derkinderen, P. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.11.014 · Cited by 62
Self-citation
Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health
Katinios, G., Casado‐Bedmar, M., Walter, S. A., Vicario, M., González-Castro, A. M., Bednarska, O., Söderholm, J. D., Hjortswang, H., & Keita, Å. V. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz328 · Cited by 58
Microbes, microglia, and pain
Dworsky-Fried, Z., Kerr, B. J., & Taylor, A. M. W. (2020) · Neurobiology of Pain · doi:10.1016/j.ynpai.2020.100045 · Cited by 64
Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review
Chey, W. D., Shah, E. D., & DuPont, H. L. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819897531 · Cited by 57
Irritable bowel syndrome and endometriosis: New insights for old diseases
Viganò, D., Zara, F., & Usai, P. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.12.017 · Cited by 57
The enteric nervous system as a regulator of intestinal epithelial barrier function in health and disease
Snoek, S. A., Verstege, M. I., Boeckxstaens, G. E., van den Wijngaard, R. M., & de Jonge, W. J. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.51 · Cited by 56
Potential for Developing Purinergic Drugs for Gastrointestinal Diseases
Ochoa‐Cortés, F., Liñán-Rico, A., Jacobson, K. A., & Christofi, F. L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000047 · Cited by 60
The Intestinal Microbiota and Irritable Bowel Syndrome
Ringel, Y., & Ringel‐Kulka, T. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000418 · Cited by 55
Histidine Prevents Cu-Induced Oxidative Stress and the Associated Decreases in mRNA from Encoding Tight Junction Proteins in the Intestine of Grass Carp (Ctenopharyngodon idella)
Jiang, W., Qu, B., Feng, L., Jiang, J., Kuang, S., Wu, P., Tang, L., Tang, W., Zhang, Y., Zhou, X., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157001 · Cited by 56
Sulfated Astragalus polysaccharide can regulate the inflammatory reaction induced by LPS in Caco2 cells
Wang, X., Wang, S., Li, Y., Wang, F., Yang, X., & Yao, J. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.05.037 · Cited by 55
Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.
Buckley, M. M., O’Mahony, S. M., & O’Malley, D. (2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8846 · Cited by 55
Succinate Modulates Intestinal Barrier Function and Inflammation Response in Pigs
Li, X., Mao, M., Zhang, Y., Yu, K., & Zhu, W. (2019) · Biomolecules · doi:10.3390/biom9090486 · Cited by 56
The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling
Mahurkar‐Joshi, S., Rankin, C. R., Videlock, E. J., Soroosh, A., Verma, A., Khandadash, A., Iliopoulos, D., Pothoulakis, C., Mayer, E. A., & Chang, L. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.040 · Cited by 55
The effects of the multispecies probiotic mixture Ecologic®Barrier on migraine: results of an open-label pilot study
de Roos, N. M., Giezenaar, C., Rovers, J. M. P., Witteman, B. J. M., Smits, M. G., & van Hemert, S. (2015) · Beneficial Microbes · doi:10.3920/bm2015.0003 · Cited by 54
Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression
Wu, R. L., Vázquez‐Roque, M. I., Carlson, P., Burton, D. D., Grover, M., Camilleri, M., & Turner, J. R. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.118 · Cited by 54
The Role of Intestinal Barrier Function in Early Life in the Development of Colitis
Anderson, R. C., Dalziel, J. E., Gopal, P. K., Bassett, S. A., Ellis, A., & Roy, N. C. (2012) · InTech eBooks · doi:10.5772/25753 · Cited by 53
Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome
Nasser, Y., Boeckxstaens, G. E., Wouters, M. M., Schemann, M., & Vanner, S. J. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12316 · Cited by 53
Limited Nesting Stress Alters Maternal Behavior and In Vivo Intestinal Permeability in Male Wistar Pup Rats
Moussaoui, N., Larauche, M. H., Biraud, M., Molet, J., Million, M., Mayer, E. A., & Taché, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155037 · Cited by 53
Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal
Fabisiak, A., Włodarczyk, J., Fabisiak, N., Storr, M., & Fichna, J. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16203 · Cited by 54
Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use
Uranga, J. A., Martı́nez, V., & Abalo, R. (2020) · Molecules · doi:10.3390/molecules25184314 · Cited by 54
Reduced E‐cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS
Wilcz-Villega, E., McClean, S., & O'Sullivan, M. (2014) · Neurogastroenterology and Motility · doi:10.1111/nmo.12262 · Cited by 52
Beneficial effects of Rifaximin in post‐infectious irritable bowel syndrome mouse model beyond gut microbiota
Jin, Y. T., Ren, X., Li, G., Li, Y., Zhang, L., Wang, H., Qian, W., & Hou, X. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13841 · Cited by 52
Inhibition of miRNA‑29a regulates intestinal barrier function in diarrhea‑predominant irritable bowel syndrome by upregulating ZO‑1 and CLDN1
Zhu, H., Xiao, X., Shi, Y., Wu, Y., Huang, Y., Li, D., Xiong, F., He, G., Chai, Y., & Tang, H. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9284 · Cited by 53
Revisiting concepts of visceral nociception in irritable bowel syndrome
Keszthelyi, D., Troost, F., Simrén, M., Ludidi, S., Kruimel, J., Conchillo, J., & Masclee, A. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00147.x · Cited by 44
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism
Barbaro, M. R., Sabatino, A. D., Cremon, C., Giuffrida, P., Fiorentino, M., Altimari, A., Bellacosa, L., Stanghellini, V., & Barbara, G. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00368.2015 · Cited by 50
Self-citation
Mast Cells and Mastocytosis
Söderholm, J. D. (2009) · Digestive Diseases · doi:10.1159/000268133 · Cited by 52
Psychosocial stress-induced intestinal permeability in healthy humans: What is the evidence?
Torre, D. L., Oudenhove, L. V., Vanuytsel, T., & Verbeke, K. (2023) · Neurobiology of Stress · doi:10.1016/j.ynstr.2023.100579 · Cited by 52
Peripheral α‐helical CRF (9‐41) does not reverse stress‐induced mast cell dependent visceral hypersensitivity in maternally separated rats
van den Wijngaard, R. M., Stanisor, O. I., van Diest, S. A., Welting, O., Wouters, M. M., de Jonge, W. J., & Boeckxstaens, G. E. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01840.x · Cited by 49
Novel insights in the role of peripheral corticotropin‐releasing factor and mast cells in stress‐induced visceral hypersensitivity
Larauche, M. H. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01867.x · Cited by 49
Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients
Ludidi, S., Jonkers, D. M. A. E., Koning, C. J., Kruimel, J. W., Mulder, L. H. C., der Vaart, I. B.-V., Conchillo, J. M., & Masclee, A. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12320 · Cited by 51
Balance of autonomic nervous system predicts who benefits from a self-management intervention program for irritable bowel syndrome
Jarrett, M. E., Cain, K. C., Barney, P. G., Burr, R. L., Naliboff, B. D., Shulman, R., Zia, J., & Heitkemper, M. M. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15067 · Cited by 48
Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function
Peters, S. A., Edogawa, S., Sundt, W. J., Dyer, R. B., Dalenberg, D. A., Mazzone, A., Singh, R. J., Moses, N., Smyrk, T. C., Weber, C., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.48 · Cited by 48
New insights into the impact of the intestinal microbiota on health and disease: a symposium report
Thomas, L. V., & Ockhuizen, T. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114511006970 · Cited by 51
From Cytokines to Toll-Like Receptors and Beyond - Current Knowledge and Future Research Needs in Irritable Bowel Syndrome
Rodríguez-Fandíño, O., Hernández-Ruíz, J., & Schmulson, M. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.4.363 · Cited by 54
Subacute stress and chronic stress interact to decrease intestinal barrier function in rats
Lauffer, A., Vanuytsel, T., Vanormelingen, C., Vanheel, H., Rasoel, S. S., Tóth, J. G., Tack, J. F., Fornari, F., & Farré, R. (2016) · Stress · doi:10.3109/10253890.2016.1154527 · Cited by 47
Somatostatin regulates tight junction proteins expression in colitis mice.
Li, X., Wang, Q., Xu, H. J., Tao, L., Lu, J., Cai, L., & Wang, C. (2014) · PubMed Central · Cited by 48

Authors: Piche, T., Barbara, G., Aubert, P., Bruley des Varannes, S., Dainese, R., Nano, J. L., Cremon, C., Stanghellini, V, De Giorgio, R., Galmiche, J. P., & Neunlist, M.
Affiliations: Inserm (FR)
University of Bologna (IT)
Corresponding author: Neunlist, M
ORCID: Barbara, G
Aubert, P
Cremon, C
Stanghellini, V
Neunlist, M
Venue: Gut
Publisher: BMJ
Published: 2008-09-29
Volume: 58
Issue: 2
Pages: 196-201
ISSN: 0017-5749 (ISSN-L)
1468-3288
DOI: 10.1136/gut.2007.140806
OpenAlex: W2161238054
Cited by: 540
References: 33
Citations by year: 2026: 18 · 2025: 20 · 2024: 26 · 2023: 23 · 2022: 40 · 2021: 32 · 2020: 31 · 2019: 31 · 2018: 24 · 2017: 39 · 2016: 36 · 2015: 26 · 2014: 46 · 2013: 34 · 2012: 38
FWCI: 25.00
Type: journal article
Language: en
Open access: green
inserm.hal.science
Licence: other-oa
Locations: Gut (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion, other-oa)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
Funders: Sanofi
Ministero dell’Istruzione, dell’Università e della Ricerca (2002052573)
Università di Bologna
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Keywords: irritable bowel syndrome, intestinal permeability, paracellular permeability, intestinal barrier integrity, colonic mucosa, soluble mediators, ZO-1, occludin, tight junction proteins, transepithelial electrical resistance, abdominal pain, Caco-2 cells, biomarkers
MeSH terms: Adult, Aged, Analysis of Variance, Biopsy, Cell Membrane, Cell Membrane Permeability, Colon, Female, Humans, Intestinal Mucosa, Male, Membrane Proteins, Middle Aged, Phosphoproteins, RNA, Messenger, Case-Control Studies, Electric Impedance, Statistics, Nonparametric, Caco-2 Cells, Reverse Transcriptase Polymerase Chain Reaction, Irritable Bowel Syndrome, Young Adult, Occludin, Zonula Occludens-1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks